Canada has made some efforts to get new products through the regulatory pathway. There's been criticism, obviously, of red tape and the difficulty of getting new therapies to market. There is an effort now by Health Canada to move toward greater international collaboration and reliance on foreign regulators, including the FDA.
Mr. Roy, perhaps, or Dr. Brockhoff, do you have any comments on this? Is this going to help?
